Sichuan Dowell Science and Technology Inc.

SZSE:300535.SZ

16.34 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
Revenue 181.693192.645163.786207.09209.134185.951122.424129.367130.988137.102112.928148.556181.159176.22123.884173.424151.05893.6351.532125.511104.77489.85976.19982.685105.92395.9371.59890.09591.65580.870.12892.26974.11875.13957.63180.81368.59773.6152.043
Cost of Revenue 118.746123.446106.276142.412144.367123.57684.578100.33890.34197.65177.79990.531116.901111.44378.59121.1685.14954.06629.97666.26754.72646.3739.95436.08659.38252.55937.7849.01147.86440.98535.25945.64236.19238.04427.60239.55433.36337.6927.498
Gross Profit 62.94869.19857.50964.67864.76862.37537.84629.02940.64839.45135.12958.02564.25864.77745.29352.26565.90939.56421.55659.24350.04843.48936.24546.59846.54143.37133.81841.08443.79139.81534.86946.62737.92637.09530.02941.25935.23435.92124.545
Gross Profit Ratio 0.3460.3590.3510.3120.310.3350.3090.2240.310.2880.3110.3910.3550.3680.3660.3010.4360.4230.4180.4720.4780.4840.4760.5640.4390.4520.4720.4560.4780.4930.4970.5050.5120.4940.5210.5110.5140.4880.472
Reseach & Development Expenses 15.4489.08612.04811.16212.711.1357.3635.567.4158.8178.00514.358.8978.92110.07616.4388.2297.0565.74814.48210.2758.6735.6046.1276.6566.8234.6946.7215.3628.6017.407.39016.023000
General & Administrative Expenses 46.962-11.37318.146-30.16837.176-3.83412.989-24.59532.837-5.16312.408-30.70438.961-8.40915.565-25.95310.496-8.51614.946-20.67612.358-4.16710.5-21.4059.475-10.61513.742-30.14715.664-4.50311.512-27.18612.04711.21910.671-22.33111.50210.6567.706
Selling & Marketing Expenses 28.00814.67712.75615.76915.17510.3828.90911.2812.4498.3978.64314.4510.099.5878.754-2.11812.43210.1869.25517.88613.49311.67111.05815.17312.3212.7789.0213.7459.7119.5377.7939.3898.9957.8756.5419.1527.3888.0625.914
SG&A 74.9713.30431.562-14.452.3516.54821.898-13.31545.2863.23421.051-16.25549.0511.17824.319-28.0722.9281.6724.202-2.7925.857.50521.558-6.23221.7952.16422.762-16.40225.3755.03419.304-17.79721.04119.09517.213-13.17918.8918.71813.62
Other Expenses -15.1930.018-6.131-0.3910.1120.089-0.7810.027-0.2350.252-0.0560.0330.2130.2160.0720.126-0.0920.002-0.125-0.0450.0050.032-0.031-0.048-0.0180.04-0.0131.3660.334-0.5361.0350.570.9390.0170.0320.9730.5310.1030.093
Operating Expenses 75.22540.43549.74248.81740.80341.74529.91840.3330.230.8629.17450.51333.6534.8233.7430.92430.72128.35329.2148.95936.09729.98827.12240.09628.60330.7123.08730.10926.03127.01919.65323.29721.39619.47417.58120.64119.35119.33613.939
Operating Income -10.79625.4967.768-21.03418.20511.6593.016-25.7983.9224.0614.8387.38927.61826.08810.03820.52633.58810.824-7.5598.67811.71813.4049.3766.92917.51414.2919.6919.90118.03414.33515.51521.51215.99416.46212.54419.52913.92914.6119.553
Operating Income Ratio -0.0590.1320.047-0.1020.0870.0630.025-0.1990.030.030.0430.050.1520.1480.0810.1180.2220.116-0.1470.0690.1120.1490.1230.0840.1650.1490.1350.110.1970.1770.2210.2330.2160.2190.2180.2420.2030.1980.184
Total Other Income Expenses Net 0.2620.590.336-0.3911.4841.191-0.7810.027-0.2350.252-0.0560.0330.2130.2160.0720.126-0.0920.002-0.125-0.0450.0050.032-0.031-0.048-0.0180.04-0.0131.570.328-0.5540.8560.5560.9390.079-0.040.5870.531-1.365-2.759
Income Before Tax -10.53425.5147.939-21.42518.31711.7482.235-25.7713.6874.3134.7817.42227.83126.30410.1120.65233.49710.826-7.6848.63311.72313.4369.3456.88217.49614.3319.67811.4718.36213.78116.37122.06916.93316.54212.50520.11614.45913.2469.323
Income Before Tax Ratio -0.0580.1320.048-0.1030.0880.0630.018-0.1990.0280.0310.0420.050.1540.1490.0820.1190.2220.116-0.1490.0690.1120.150.1230.0830.1650.1490.1350.1270.20.1710.2330.2390.2280.220.2170.2490.2110.180.179
Income Tax Expense -8.6896.2891.814-1.0865.1552.1351.118-0.540.6153.1610.976-1.3592.5853.4491.304-0.6512.2880.273-0.059-1.6172.1462.1791.1380.9982.5981.9431.6091.6652.4161.8252.3333.1122.7532.5541.8222.4662.6692.6091.374
Net Income -0.00122.2267.954-5.02118.59811.1653.686-12.0983.532.2664.4757.39525.73823.2019.50222.0131.24710.994-7.22210.2839.60311.2418.2425.97214.93612.4298.079.80515.94511.96414.0418.94114.19313.99110.69617.6711.79610.6777.991
Net Income Ratio -00.1150.049-0.0240.0890.060.03-0.0940.0270.0170.040.050.1420.1320.0770.1270.2070.117-0.140.0820.0920.1250.1080.0720.1410.130.1130.1090.1740.1480.20.2050.1910.1860.1860.2190.1720.1450.154
EPS 00.210.076-0.0480.180.110.035-0.120.0350.0220.0440.0730.250.230.0910.240.30.11-0.070.10.0920.10.0830.0610.140.110.0810.10.160.120.140.190.170.190.140.230.160.130.11
EPS Diluted 00.210.076-0.0480.180.110.035-0.120.0350.0220.0440.0730.250.230.0910.240.30.11-0.0690.10.0920.10.0830.0610.140.110.0810.10.160.120.140.190.170.190.140.230.160.130.11
EBITDA -9.05528.13615.985-2.59436.16717.93514.923-12.90213.22915.78415.4416.8933836.26519.67529.7642.2619.829-0.89817.48317.47818.05913.8146.50219.79312.66111.11815.38718.44514.93616.02725.13516.91818.15615.30817.41315.88216.58513.564
EBITDA Ratio -0.050.1480.0980.0690.1110.0960.042-0.0870.050.0370.0510.0560.170.1730.0860.1230.240.122-0.1610.0780.1210.1540.1170.090.1870.1340.1550.1790.2010.1830.2290.270.2280.2420.2590.2260.2390.2680.262